Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees

✍ Scribed by Antonio Ponzetto; Francesco Negro; Hans Popper; Ferruccio Bonino; Ronald Engle; Mario Rizzetto; Robert H. Purcell; John L. Gerin

• Publisher: John Wiley and Sons
• Year: 1988
• Tongue: English
• Weight: 898 KB
• Volume: 8
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1002/hep.1840080631

✦ Synopsis

Five consecutive passages of hepatitis delta virus in hepatitis B virus carrier chimpanzees were performed in order to further characterize the infectious and pathogenic nature of this naturally occurring defective virus. Three animals received identical inocula at fourth passage in order to assess individual animal variation as a factor in the course of infection and disease. Acute hepatitis delta virus infection occurred in all hepatitis B virus carrier chimpanzees as demonstrated by coincident intrahepatic hepatitis delta antigen, serum hepatitis delta antigen and serum hepatitis delta virus RNA followed by seroconversion to antibody to hepatitis delta antigen. In all animals, acute hepatitis was temporally associated with hepatitis delta virus infection and was self-limited. The incubation period to hepatitis shortened with passage, whereas biochemical and histologic evidence of liver diseases increased. The marked increase in liver disease with passage was not associated with increasing markers of hepatitis delta virus replication or expression, thus indicating that adaptation to the chimpanzee by serial passage resulted in increased hepatitis delta virus virulence. The duration of hepatitis due to hepatitis delta virus infection in three chimpanzees which received the same inoculum varied from 1 to 8 months. The observations of passage adaptation and individual host variation in this experimental model of hepatitis delta virus disease parallel known pathogenic variations in human hepatitis delta virus infection.

Hepatitis delta virus (HDV) is a naturally occurring defective pathogen of man which depends on the hepatitis B virus (HBV) for its replication (1, 2). HDV circulates in the plasma as a 36-nm particle consisting of a small RNA (1.7 kilobases), hepatitis delta antigen (HDAg) and a coat of the surface antigen provided by